A patch which delivers a vaccine against Alzheimer's disease through the skin has been shown to be safe and effective, a study has found.
University of South Florida researchers reported the patch was able to clear brain-damaging plaques from mice.
They say it may be a simpler way of protecting people against the disease than a conventional injected vaccine.
UK experts said the Proceedings of the National Academy of Sciences study was "potentially very exciting".
Alzheimer's is linked with the build up of a protein called beta amyloid in the brain, where it clumps together to form damaging plaques.
Continue reading "Alzheimer's vaccine 'in a patch'" »
A recently approved project of the sixth EU Framework Programme – MimoVax – is focussing on a new target for an Alzheimer's vaccine. The project, coordinated by the Austrian company Affiris GmbH, centres on the use of immune reactions to combat previously overlooked forms of the beta-amyloid that cause Alzheimer's disease. It is being run by seven partner organisations from three countries and has received an exceptionally positive response from Brussels – as well as Euro 2.4 million in financial support.
The signing of the contract yesterday signalled the start of the active
phase of the EU MimoVax project. The project is part of the sixth EU
Framework Programme and is seeking to develop an Alzheimer's vaccine that targets specific types of beta-amyloid, the causative agent of Alzheimer's disease.
Continue reading "EU team develops new Alzheimer's vaccine from Austria" »